New York City, NY -- (SBWIRE) -- 10/09/2013 -- StockMarketIntel.com issues a special report on the following stocks: FreeSeas Inc (NASDAQ:FREE), Sirius XM Radio Inc (NASDAQ:SIRI), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Titan Pharmaceuticals, Inc. (OTCBB:TTNP)
FreeSeas Inc (NASDAQ:FREE) declined -16.29%, trading on 11.82 million shares, to end the trade at $0.520. The stock changed hands in a range of $0.50 to $0.68, bringing its market capitalization to about $341,993. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.17 and was moved to the maximum level of $5.80. FreeSeas Inc. (FreeSeas) is a parent holding company of its ship-owning companies. The Company’s fleet consists of six Handysize vessels and one Handymax vessel that carry a variety of drybulk commodities, including iron ore, grain and coal, which are referred to as bulks, as well as bauxite, phosphate, fertilizers, steel products, cement, sugar and rice, or minor bulks.
Will FREE Get Buyers Even After The Recent Rally? Find Out Here
Sirius XM Radio Inc (NASDAQ:SIRI) declined -2.78%, to complete the trading session at $3.85, with a total volume of 56.86 million shares. The stock, on average, trades on a volume of 36.11 million shares. It floated in a range of $3.85 to $4.00 during the last trading session, with a beta value of 1.92. Its market capitalization now moved to about $23.91 billion. In the past 52 weeks, the share price has not declined below $2.55 and above $4.00. Sirius XM Radio Inc. broadcasts its music, sports, entertainment, comedy, talk, news, traffic and weather channels in the United States on a subscription fee basis through its two satellite radio systems. Subscribers can also receive certain of its music and other channels over the Internet, including through applications for mobile devices.
Will SIRI Bounce Back After yesterday’s Sharp Sell off? Find Out Here
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) recorded a fall of -15.46% and was in a range of $22.30-$27.62 before closing at $23.30. The stock completed the day with a total volume of 12.39 million shares, versus an average volume of 1.98 million shares. The share price hit its 52-week low of $1.80 and $29.73 was the best price. ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. The Company has four product candidates in clinical development led by pimavanserin, which is in Phase III development as a first-in-class treatment for Parkinson's disease psychosis.
Is it the Right to Grab ACAD after the Recent Slump? Get Free Trend Analysis Here
Titan Pharmaceuticals, Inc. (OTCBB:TTNP) declined -7.38% yesterday, bringing its market capitalization around $89.07 million. The share price, after opening at $1.20, made a high of $1.27 and hovered above $0.90 to end the day at $1.08. The total number of shares that changed hands during the session was4.50 million shares, as compared to average trading volume of 621,153 shares. Titan Pharmaceuticals, Inc. is a biopharmaceutical company developing proprietary therapeutics primarily for the treatment of central nervous system (CNS) disorders. The Company is focused primarily on clinical development of the following products: Probuphine for the treatment of opioid addiction; Iloperidone: for the treatment of schizophrenia and related psychotic disorders; and Spheramine for the treatment of advanced Parkinson’s disease.Titan Pharmaceuticals is directly developing its product candidates and also utilizing corporate partnerships, including a collaboration with Bayer Schering Pharma AG, Germany (Bayer Schering) for the development of Spheramine to treat Parkinson’s disease, and Vanda Pharmaceuticals, Inc. (Vanda) for the development of iloperidone for the treatment of schizophrenia and related psychotic disorders.
Will TTNP Reach the Bottom after Yesterday’s Correction? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)